SynCore Biotechnology Co.,Ltd (TPEX:4192)

TPEX:4192 Revenue

SynCore Biotechnology Co.,Ltd had revenue of 6.12M TWD in the quarter ending March 31, 2026, with 13.67% growth. This brings the company's revenue in the last twelve months to 27.78M, up 14.11% year-over-year. In the year 2025, SynCore Biotechnology Co.,Ltd had annual revenue of 27.04M with 15.88% growth.

• Revenue (ttm): 27.78M
• Revenue Growth: +14.11%
• P/S Ratio: 25.32
• Revenue / Employee: 694.48K
• Employees: 40
• Market Cap: 703.29M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	27.04M	3.71M	15.88%
Dec 31, 2024	23.34M	3.14M	15.55%
Dec 31, 2023	20.20M	4.34M	27.36%
Dec 31, 2022	15.86M	8.92M	128.52%
Dec 31, 2021	6.94M	-6.40M	-47.97%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error